TELA Bio, Inc. (TELA) DCF Valuation

TELA Bio, Inc. (TELA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

TELA Bio, Inc. (TELA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the TELA Bio, Inc. (TELA) DCF Calculator! Utilize accurate TELA financial data, adjust growth projections and expenses, and instantly observe how these modifications influence TELA's intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 15.4 18.2 29.5 41.4 58.5 82.0 115.1 161.6 226.8 318.3
Revenue Growth, % 0 17.91 61.77 40.58 41.13 40.35 40.35 40.35 40.35 40.35
EBITDA -18.2 -24.7 -29.1 -39.1 -40.6 -75.9 -106.6 -149.5 -209.9 -294.6
EBITDA, % -118.05 -135.64 -98.92 -94.3 -69.51 -92.55 -92.55 -92.55 -92.55 -92.55
Depreciation .6 .5 .5 1.2 .8 2.1 2.9 4.1 5.8 8.1
Depreciation, % 3.77 2.88 1.82 2.87 1.38 2.54 2.54 2.54 2.54 2.54
EBIT -18.8 -25.2 -29.7 -40.2 -41.4 -76.8 -107.8 -151.3 -212.3 -298.0
EBIT, % -121.82 -138.53 -100.73 -97.17 -70.9 -93.61 -93.61 -93.61 -93.61 -93.61
Total Cash 54.6 74.4 43.9 42.0 46.7 78.7 110.5 155.1 217.7 305.5
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 2.8 2.7 4.2 6.6 9.7
Account Receivables, % 18.36 14.73 14.37 15.99 16.66
Inventories 4.6 3.9 7.7 11.8 13.2 21.0 29.5 41.4 58.2 81.6
Inventories, % 29.8 21.45 25.99 28.47 22.52 25.65 25.65 25.65 25.65 25.65
Accounts Payable 3.2 .7 2.4 1.5 1.7 6.4 8.9 12.6 17.6 24.7
Accounts Payable, % 20.53 3.58 8.19 3.7 2.85 7.77 7.77 7.77 7.77 7.77
Capital Expenditure -2.7 -.2 -.6 -1.9 -.6 -4.3 -6.0 -8.4 -11.8 -16.6
Capital Expenditure, % -17.46 -0.91693 -2.13 -4.52 -1.05 -5.21 -5.21 -5.21 -5.21 -5.21
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -21.7 -27.9 -32.2 -40.3 -41.4 -76.8 -107.8 -151.3 -212.3 -298.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -28.0 -29.2 -35.8 -48.4 -45.6 -85.6 -122.1 -171.3 -240.5 -337.5
WACC, % 10.43 10.43 10.43 10.43 10.43 10.43 10.43 10.43 10.43 10.43
PV UFCF
SUM PV UFCF -672.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -344
Terminal Value -4,084
Present Terminal Value -2,487
Enterprise Value -3,159
Net Debt -6
Equity Value -3,153
Diluted Shares Outstanding, MM 23
Equity Value Per Share -137.88

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to develop various scenarios.
  • Real-World Data: TELA Bio, Inc.'s (TELA) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model that adjusts to your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.

Key Features

  • Accurate TELA Bio Financials: Gain access to reliable pre-loaded historical data and future forecasts.
  • Tailorable Forecast Inputs: Modify highlighted cells for parameters like WACC, growth rates, and profit margins.
  • Real-Time Calculations: Automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help visualize your valuation outcomes.
  • Designed for All Users: An easy-to-navigate format suitable for investors, CFOs, and consultants alike.

How It Works

  • Download: Obtain the comprehensive Excel file featuring TELA Bio, Inc.'s (TELA) financial data.
  • Customize: Tailor your forecasts, including revenue growth, EBITDA %, and WACC to your preferences.
  • Update Automatically: Watch as the intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and instantly compare the results.
  • Make Decisions: Leverage the valuation outcomes to inform your investment choices.

Why Choose This Calculator for TELA Bio, Inc. (TELA)?

  • Designed for Experts: A sophisticated tool utilized by industry analysts, CFOs, and healthcare consultants.
  • Accurate Data: TELA Bio’s historical and projected financials are preloaded for precision.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.

Who Should Use TELA Bio, Inc. (TELA)?

  • Investors: Assess TELA's fair value to inform your investment strategies.
  • CFOs: Utilize a comprehensive DCF model for accurate financial reporting and analysis.
  • Consultants: Easily modify the template for client valuation reports related to TELA.
  • Entrepreneurs: Discover financial modeling techniques employed by leading biotech firms.
  • Educators: Implement this resource as a teaching aid for valuation practices in the biotech sector.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations for TELA Bio, Inc. (TELA).
  • Real-World Data: TELA Bio's historical and projected financials preloaded for analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
  • Financial Statements: Full annual and quarterly breakdowns for deeper insights into TELA's performance.
  • Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to TELA Bio, Inc. (TELA).
  • Dashboard with Visual Outputs: Charts and tables providing clear, actionable results for stakeholders.

No products were found matching.